APO Research
Talk to an analyst

APO RESEARCH · REPORT

Rosiglitazone

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Rosiglitazone Market Outlook and Growth Opportunities 2026

22 December 2025194 pages

Choose your research edition.

Industry ResearchRosiglitazone Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Rosiglitazone Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Rosiglitazone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rosiglitazone Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Rosiglitazone Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Rosiglitazone market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Rosiglitazone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Rosiglitazone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Rosiglitazone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Rosiglitazone market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Rosiglitazone market include Wanma Pharma, Taiji Group, Jingxin Pharma, Huanghe Pharma, Shengjitang Pharma, GSK, Hengrui Pharma and STADA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Rosiglitazone market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Rosiglitazone and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Rosiglitazone sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Rosiglitazone market size, projected growth trends, production technologies, key applications, and end-use industries.

Rosiglitazone Segment by Company

Wanma Pharma

Taiji Group

Jingxin Pharma

Huanghe Pharma

Shengjitang Pharma

GSK

Hengrui Pharma

STADA

Rosiglitazone Segment by Type

Rosiglitazone Hydrochloride Tablets

Rosiglitazone Maleate Tablets

Rosiglitazone Tablets

Others

Rosiglitazone Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Rosiglitazone Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Rosiglitazone status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Rosiglitazone market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Rosiglitazone significant trends, drivers, influence factors in global and regions.

6. To analyze Rosiglitazone competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rosiglitazone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rosiglitazone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rosiglitazone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Rosiglitazone market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Rosiglitazone industry.

Chapter 3: Detailed analysis of Rosiglitazone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Rosiglitazone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Rosiglitazone in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Rosiglitazone Industry Trends Table 2. Rosiglitazone Industry Drivers Table 3. Rosiglitazone Industry Opportunities and Challenges Table 4. Rosiglitazone Industry Restraints Table 5. Global Rosiglitazone Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Rosiglitazone Revenue Share by Company (2021-2026) Table 7. Global Rosiglitazone Sales Volume by Company (kg) & (2021-2026) Table 8. Global Rosiglitazone Sales Volume Share by Company (2021-2026) Table 9. Global Rosiglitazone Average Price (US$/kg) of Company (2021-2026) Table 10. Global Rosiglitazone Company Ranking, (2024-2026) & (USD Million) Table 11. Global Rosiglitazone Key Company Manufacturing Base & Headquarters Table 12. Global Rosiglitazone Company, Product Type & Application Table 13. Global Rosiglitazone Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Rosiglitazone by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Rosiglitazone Hydrochloride Tablets Table 18. Significant Companies of Rosiglitazone Maleate Tablets Table 19. Significant Companies of Rosiglitazone Tablets Table 20. Significant Companies of Others Table 21. Global Rosiglitazone Sales Volume by Type 2021 VS 2025 VS 2032 (kg) Table 22. Global Rosiglitazone Sales Volume by Type (2021-2026) & (kg) Table 23. Global Rosiglitazone Sales Volume by Type (2027-2032) & (kg) Table 24. Global Rosiglitazone Sales Volume Share by Type (2021-2026) Table 25. Global Rosiglitazone Sales Volume Share by Type (2027-2032) Table 26. Global Rosiglitazone Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Rosiglitazone Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Rosiglitazone Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Rosiglitazone Sales Value Share by Type (2021-2026) Table 30. Global Rosiglitazone Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Hospital Pharmacies Table 32. Significant Companies of Online Pharmacies Table 33. Significant Companies of Retail Pharmacies Table 34. Global Rosiglitazone Sales Volume by Application 2021 VS 2025 VS 2032 (kg) Table 35. Global Rosiglitazone Sales Volume by Application (2021-2026) & (kg) Table 36. Global Rosiglitazone Sales Volume by Application (2027-2032) & (kg) Table 37. Global Rosiglitazone Sales Volume Share by Application (2021-2026) Table 38. Global Rosiglitazone Sales Volume Share by Application (2027-2032) Table 39. Global Rosiglitazone Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Rosiglitazone Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Rosiglitazone Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Rosiglitazone Sales Value Share by Application (2021-2026) Table 43. Global Rosiglitazone Sales Value Share by Application (2027-2032) Table 44. Global Rosiglitazone Sales by Region: 2021 VS 2025 VS 2032 (kg) Table 45. Global Rosiglitazone Sales by Region (2021-2026) & (kg) Table 46. Global Rosiglitazone Sales Market Share by Region (2021-2026) Table 47. Global Rosiglitazone Sales by Region (2027-2032) & (kg) Table 48. Global Rosiglitazone Sales Market Share by Region (2027-2032) Table 49. Global Rosiglitazone Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Rosiglitazone Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Rosiglitazone Sales Value Share by Region (2021-2026) Table 52. Global Rosiglitazone Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Rosiglitazone Sales Value Share by Region (2027-2032) Table 54. Global Rosiglitazone Market Average Price (US$/kg) by Region (2021-2026) Table 55. Global Rosiglitazone Market Average Price (US$/kg) by Region (2027-2032) Table 56. Global Rosiglitazone Sales by Country: 2021 VS 2025 VS 2032 (kg) Table 57. Global Rosiglitazone Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Rosiglitazone Sales by Country (2021-2026) & (kg) Table 59. Global Rosiglitazone Sales Market Share by Country (2021-2026) Table 60. Global Rosiglitazone Sales by Country (2027-2032) & (kg) Table 61. Global Rosiglitazone Sales Market Share by Country (2027-2032) Table 62. Global Rosiglitazone Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Rosiglitazone Sales Value Market Share by Country (2021-2026) Table 64. Global Rosiglitazone Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Rosiglitazone Sales Value Market Share by Country (2027-2032) Table 66. Wanma Pharma Company Information Table 67. Wanma Pharma Business Overview Table 68. Wanma Pharma Rosiglitazone Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 69. Wanma Pharma Rosiglitazone Product Portfolio Table 70. Wanma Pharma Recent Development Table 71. Taiji Group Company Information Table 72. Taiji Group Business Overview Table 73. Taiji Group Rosiglitazone Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 74. Taiji Group Rosiglitazone Product Portfolio Table 75. Taiji Group Recent Development Table 76. Jingxin Pharma Company Information Table 77. Jingxin Pharma Business Overview Table 78. Jingxin Pharma Rosiglitazone Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 79. Jingxin Pharma Rosiglitazone Product Portfolio Table 80. Jingxin Pharma Recent Development Table 81. Huanghe Pharma Company Information Table 82. Huanghe Pharma Business Overview Table 83. Huanghe Pharma Rosiglitazone Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 84. Huanghe Pharma Rosiglitazone Product Portfolio Table 85. Huanghe Pharma Recent Development Table 86. Shengjitang Pharma Company Information Table 87. Shengjitang Pharma Business Overview Table 88. Shengjitang Pharma Rosiglitazone Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 89. Shengjitang Pharma Rosiglitazone Product Portfolio Table 90. Shengjitang Pharma Recent Development Table 91. GSK Company Information Table 92. GSK Business Overview Table 93. GSK Rosiglitazone Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 94. GSK Rosiglitazone Product Portfolio Table 95. GSK Recent Development Table 96. Hengrui Pharma Company Information Table 97. Hengrui Pharma Business Overview Table 98. Hengrui Pharma Rosiglitazone Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 99. Hengrui Pharma Rosiglitazone Product Portfolio Table 100. Hengrui Pharma Recent Development Table 101. STADA Company Information Table 102. STADA Business Overview Table 103. STADA Rosiglitazone Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 104. STADA Rosiglitazone Product Portfolio Table 105. STADA Recent Development Table 106. Key Raw Materials Table 107. Raw Materials Key Suppliers Table 108. Rosiglitazone Distributors List Table 109. Rosiglitazone Customers List Table 110. Research Programs/Design for This Report Table 111. Authors List of This Report Table 112. Secondary Sources Table 113. Primary Sources List of Figures Figure 1. Rosiglitazone Product Image Figure 2. Global Rosiglitazone Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rosiglitazone Sales Value (2021-2032) & (US$ Million) Figure 4. Global Rosiglitazone Sales (2021-2032) & (kg) Figure 5. Global Rosiglitazone Sales Average Price (US$/kg) & (2021-2032) Figure 6. Global Rosiglitazone Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Rosiglitazone Hydrochloride Tablets Image Figure 10. Rosiglitazone Maleate Tablets Image Figure 11. Rosiglitazone Tablets Image Figure 12. Others Image Figure 13. Global Rosiglitazone Sales Volume by Type (2021 VS 2025 VS 2032) & (kg) Figure 14. Global Rosiglitazone Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Rosiglitazone Sales Volume Share by Type (2021-2032) Figure 16. Global Rosiglitazone Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Rosiglitazone Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Rosiglitazone Sales Value Share by Type (2021-2032) Figure 19. Hospital Pharmacies Image Figure 20. Online Pharmacies Image Figure 21. Retail Pharmacies Image Figure 22. Global Rosiglitazone Sales Volume by Application (2021 VS 2025 VS 2032) & (kg) Figure 23. Global Rosiglitazone Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Rosiglitazone Sales Volume Share by Application (2021-2032) Figure 25. Global Rosiglitazone Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Rosiglitazone Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Rosiglitazone Sales Value Share by Application (2021-2032) Figure 28. Global Rosiglitazone Sales by Region: 2021 VS 2025 VS 2032 (kg) Figure 29. Global Rosiglitazone Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Rosiglitazone Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Rosiglitazone Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Rosiglitazone Sales Value (2021-2032) & (US$ Million) Figure 33. North America Rosiglitazone Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Rosiglitazone Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Rosiglitazone Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Rosiglitazone Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Rosiglitazone Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Rosiglitazone Sales Value (2021-2032) & (US$ Million) Figure 39. South America Rosiglitazone Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Rosiglitazone Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Rosiglitazone Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Rosiglitazone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Rosiglitazone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Rosiglitazone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Rosiglitazone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Rosiglitazone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Rosiglitazone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Rosiglitazone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Rosiglitazone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Rosiglitazone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Rosiglitazone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Rosiglitazone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Rosiglitazone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Rosiglitazone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Rosiglitazone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Rosiglitazone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Rosiglitazone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Rosiglitazone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Rosiglitazone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Rosiglitazone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Rosiglitazone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Rosiglitazone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Rosiglitazone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Rosiglitazone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Rosiglitazone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Rosiglitazone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Rosiglitazone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Rosiglitazone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Rosiglitazone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Rosiglitazone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Rosiglitazone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Rosiglitazone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Rosiglitazone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Rosiglitazone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Rosiglitazone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Rosiglitazone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Rosiglitazone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Rosiglitazone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Rosiglitazone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Rosiglitazone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Rosiglitazone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Rosiglitazone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Rosiglitazone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Rosiglitazone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Rosiglitazone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Rosiglitazone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Rosiglitazone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Rosiglitazone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Rosiglitazone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Rosiglitazone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Rosiglitazone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Rosiglitazone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Rosiglitazone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Rosiglitazone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Rosiglitazone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Rosiglitazone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Rosiglitazone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Rosiglitazone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Rosiglitazone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Rosiglitazone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Rosiglitazone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Rosiglitazone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Rosiglitazone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Rosiglitazone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Rosiglitazone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Rosiglitazone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Rosiglitazone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Rosiglitazone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Rosiglitazone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Rosiglitazone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Rosiglitazone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Rosiglitazone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Rosiglitazone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Rosiglitazone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Rosiglitazone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Rosiglitazone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Rosiglitazone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Rosiglitazone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Rosiglitazone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Rosiglitazone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Rosiglitazone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Rosiglitazone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Rosiglitazone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Rosiglitazone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Rosiglitazone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Rosiglitazone Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Rosiglitazone Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Rosiglitazone Hydrochloride Tablets
  • Rosiglitazone Maleate Tablets
  • Rosiglitazone Tablets
  • Others
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Wanma Pharma
  • Taiji Group
  • Jingxin Pharma
  • Huanghe Pharma
  • Shengjitang Pharma
  • GSK
  • Hengrui Pharma
  • STADA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Rosiglitazone Sales Value (2021-2032)
  4. 1.2.2 Global Rosiglitazone Sales Volume (2021-2032)
  5. 1.2.3 Global Rosiglitazone Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Rosiglitazone Market Dynamics
  1. 2.1 Rosiglitazone Industry Trends
  2. 2.2 Rosiglitazone Industry Drivers
  3. 2.3 Rosiglitazone Industry Opportunities and Challenges
  4. 2.4 Rosiglitazone Industry Restraints
3 Rosiglitazone Market by Company
  1. 3.1 Global Rosiglitazone Company Revenue Ranking in 2025
  2. 3.2 Global Rosiglitazone Revenue by Company (2021-2026)
  3. 3.3 Global Rosiglitazone Sales Volume by Company (2021-2026)
  4. 3.4 Global Rosiglitazone Average Price by Company (2021-2026)
  5. 3.5 Global Rosiglitazone Company Ranking (2024-2026)
  6. 3.6 Global Rosiglitazone Company Manufacturing Base and Headquarters
  7. 3.7 Global Rosiglitazone Company Product Type and Application
  8. 3.8 Global Rosiglitazone Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Rosiglitazone Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Rosiglitazone Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Rosiglitazone Market by Type
  1. 4.1 Rosiglitazone Type Introduction
  2. 4.1.1 Rosiglitazone Hydrochloride Tablets
  3. 4.1.2 Rosiglitazone Maleate Tablets
  4. 4.1.3 Rosiglitazone Tablets
  5. 4.1.4 Others
  6. 4.2 Global Rosiglitazone Sales Volume by Type
  7. 4.2.1 Global Rosiglitazone Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Rosiglitazone Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Rosiglitazone Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Rosiglitazone Sales Value by Type
  11. 4.3.1 Global Rosiglitazone Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Rosiglitazone Sales Value by Type (2021-2032)
  13. 4.3.3 Global Rosiglitazone Sales Value Share by Type (2021-2032)
5 Rosiglitazone Market by Application
  1. 5.1 Rosiglitazone Application Introduction
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Retail Pharmacies
  5. 5.2 Global Rosiglitazone Sales Volume by Application
  6. 5.2.1 Global Rosiglitazone Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Rosiglitazone Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Rosiglitazone Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Rosiglitazone Sales Value by Application
  10. 5.3.1 Global Rosiglitazone Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Rosiglitazone Sales Value by Application (2021-2032)
  12. 5.3.3 Global Rosiglitazone Sales Value Share by Application (2021-2032)
6 Rosiglitazone Regional Sales and Value Analysis
  1. 6.1 Global Rosiglitazone Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Rosiglitazone Sales by Region (2021-2032)
  3. 6.2.1 Global Rosiglitazone Sales by Region: 2021-2026
  4. 6.2.2 Global Rosiglitazone Sales by Region (2027-2032)
  5. 6.3 Global Rosiglitazone Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Rosiglitazone Sales Value by Region (2021-2032)
  7. 6.4.1 Global Rosiglitazone Sales Value by Region: 2021-2026
  8. 6.4.2 Global Rosiglitazone Sales Value by Region (2027-2032)
  9. 6.5 Global Rosiglitazone Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Rosiglitazone Sales Value (2021-2032)
  12. 6.6.2 North America Rosiglitazone Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Rosiglitazone Sales Value (2021-2032)
  15. 6.7.2 Europe Rosiglitazone Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Rosiglitazone Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Rosiglitazone Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Rosiglitazone Sales Value (2021-2032)
  21. 6.9.2 South America Rosiglitazone Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Rosiglitazone Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Rosiglitazone Sales Value Share by Country, 2025 VS 2032
7 Rosiglitazone Country-level Sales and Value Analysis
  1. 7.1 Global Rosiglitazone Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Rosiglitazone Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Rosiglitazone Sales by Country (2021-2032)
  4. 7.3.1 Global Rosiglitazone Sales by Country (2021-2026)
  5. 7.3.2 Global Rosiglitazone Sales by Country (2027-2032)
  6. 7.4 Global Rosiglitazone Sales Value by Country (2021-2032)
  7. 7.4.1 Global Rosiglitazone Sales Value by Country (2021-2026)
  8. 7.4.2 Global Rosiglitazone Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Rosiglitazone Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Rosiglitazone Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Rosiglitazone Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Rosiglitazone Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Rosiglitazone Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Rosiglitazone Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Rosiglitazone Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Rosiglitazone Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Rosiglitazone Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Rosiglitazone Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Rosiglitazone Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Rosiglitazone Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Rosiglitazone Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Rosiglitazone Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Rosiglitazone Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Rosiglitazone Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Rosiglitazone Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Rosiglitazone Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Rosiglitazone Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Rosiglitazone Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Rosiglitazone Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Rosiglitazone Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Rosiglitazone Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Rosiglitazone Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Rosiglitazone Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Rosiglitazone Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Rosiglitazone Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Rosiglitazone Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Rosiglitazone Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Rosiglitazone Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Rosiglitazone Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Rosiglitazone Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Rosiglitazone Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Rosiglitazone Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Rosiglitazone Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Rosiglitazone Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Rosiglitazone Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Rosiglitazone Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Rosiglitazone Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Rosiglitazone Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Rosiglitazone Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Rosiglitazone Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Rosiglitazone Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Rosiglitazone Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Rosiglitazone Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Rosiglitazone Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Rosiglitazone Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Rosiglitazone Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Rosiglitazone Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Rosiglitazone Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Rosiglitazone Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Rosiglitazone Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Rosiglitazone Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Rosiglitazone Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Rosiglitazone Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Rosiglitazone Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Rosiglitazone Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Rosiglitazone Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Rosiglitazone Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Rosiglitazone Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Rosiglitazone Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Rosiglitazone Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Rosiglitazone Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Rosiglitazone Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Rosiglitazone Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Rosiglitazone Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Rosiglitazone Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Rosiglitazone Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Rosiglitazone Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Rosiglitazone Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Rosiglitazone Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Rosiglitazone Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Rosiglitazone Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Rosiglitazone Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Rosiglitazone Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Rosiglitazone Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Rosiglitazone Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Rosiglitazone Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Rosiglitazone Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Rosiglitazone Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Rosiglitazone Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Rosiglitazone Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Rosiglitazone Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Rosiglitazone Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Wanma Pharma
  2. 8.1.1 Wanma Pharma Company Information
  3. 8.1.2 Wanma Pharma Business Overview
  4. 8.1.3 Wanma Pharma Rosiglitazone Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Wanma Pharma Rosiglitazone Product Portfolio
  6. 8.1.5 Wanma Pharma Recent Developments
  7. 8.2 Taiji Group
  8. 8.2.1 Taiji Group Company Information
  9. 8.2.2 Taiji Group Business Overview
  10. 8.2.3 Taiji Group Rosiglitazone Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Taiji Group Rosiglitazone Product Portfolio
  12. 8.2.5 Taiji Group Recent Developments
  13. 8.3 Jingxin Pharma
  14. 8.3.1 Jingxin Pharma Company Information
  15. 8.3.2 Jingxin Pharma Business Overview
  16. 8.3.3 Jingxin Pharma Rosiglitazone Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Jingxin Pharma Rosiglitazone Product Portfolio
  18. 8.3.5 Jingxin Pharma Recent Developments
  19. 8.4 Huanghe Pharma
  20. 8.4.1 Huanghe Pharma Company Information
  21. 8.4.2 Huanghe Pharma Business Overview
  22. 8.4.3 Huanghe Pharma Rosiglitazone Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Huanghe Pharma Rosiglitazone Product Portfolio
  24. 8.4.5 Huanghe Pharma Recent Developments
  25. 8.5 Shengjitang Pharma
  26. 8.5.1 Shengjitang Pharma Company Information
  27. 8.5.2 Shengjitang Pharma Business Overview
  28. 8.5.3 Shengjitang Pharma Rosiglitazone Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Shengjitang Pharma Rosiglitazone Product Portfolio
  30. 8.5.5 Shengjitang Pharma Recent Developments
  31. 8.6 GSK
  32. 8.6.1 GSK Company Information
  33. 8.6.2 GSK Business Overview
  34. 8.6.3 GSK Rosiglitazone Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 GSK Rosiglitazone Product Portfolio
  36. 8.6.5 GSK Recent Developments
  37. 8.7 Hengrui Pharma
  38. 8.7.1 Hengrui Pharma Company Information
  39. 8.7.2 Hengrui Pharma Business Overview
  40. 8.7.3 Hengrui Pharma Rosiglitazone Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Hengrui Pharma Rosiglitazone Product Portfolio
  42. 8.7.5 Hengrui Pharma Recent Developments
  43. 8.8 STADA
  44. 8.8.1 STADA Company Information
  45. 8.8.2 STADA Business Overview
  46. 8.8.3 STADA Rosiglitazone Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 STADA Rosiglitazone Product Portfolio
  48. 8.8.5 STADA Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Rosiglitazone Value Chain Analysis
  2. 9.1.1 Rosiglitazone Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Rosiglitazone Sales Mode & Process
  6. 9.2 Rosiglitazone Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Rosiglitazone Distributors
  9. 9.2.3 Rosiglitazone Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst